Respuesta humoral inducida por la vacuna BBIBP-CorV/Sinopharm COVID-19 en trabajadores de primera línea / BBIBP-CorV/Sinopharm COVID-19 vaccine-induced humoral response in frontline workers

Con la llegada de la vacuna contra el COVID-19 se evidenció la disminución de casos de Infección por SARS-CoV-2. El objetivo del estudio fue cuantificar la producción de anticuerpos neutralizantes (An) e inmunoglobulina G (S-IgG) en trabajadores de primera línea inmunizados con dos dosis de la vacuna BBIBP-CorV/Sinopharma. Se realizó un estudio observacional analítico transversal en personal de salud inmunizado con la vacuna inactivada (BBIBP-CorV). Sus muestras sanguíneas se recogieron tres meses después de la segunda dosis, para medir las respuestas de anticuerpos (An, S-IgG). De un total de 172 personas evaluadas, 110 (64%) personas ya habían tenido COVID-19 antes de ingresar al estudio, los títulos de An fueron superiores a 10 AU/mL en el 60,5% de los vacunados y el 89,3% mostró S-IgG superior a 50 UA/mL. Los trabajadores mayores de 60 años fueron el grupo que no desarrolló suficientes anticuerpos. La correlación de An y S-IgG fue positiva (r=0,84) (p<0,001). La administración de dos dosis de la vacuna inactivada BBIBP-CorV/Sinopharma provocó una notable respuesta An y S-IgG, excepto en mayores de 60 años(AU)

With the arrival of the vaccine against COVID-19, the decrease in cases of SARS-CoV-2 infection was evidenced. The objective of the study was to quantify the production of neutralizing antibodies (An) and immunoglobulin G (S-IgG) in frontline workers immunized with two doses of the BBIBP-CorV/Sinopharma vaccine. A cross-sectional analytical observational study was carried out in health personnel immunized with the inactivated vaccine (BBIBP-CorV). Their blood samples were collected three months after the second dose, to measure antibody responses (An, S-IgG). Of a total of 172 people evaluated, 110 (64%) people already had COVID-19 before entering the study, An titers were greater than 10 AU/mL in 60.5% of those vaccinated and 89, 3% showed S-IgG greater than 50 AU/mL. Workers older than 60 years were the group that did not develop enough antibodies. The correlation of An and S-IgG was positive (r=0.84) (p<0.001). The administration of two doses of the inactivated BBIBP-CorV/Sinopharma vaccine caused a notable An and S-IgG response, except in those over 60 years of age(AU)

An atypical clinical presentation for the first isolation of canid herpesvirus 1 in Argentina / Uma apresentação clínica atípica para o primeiro isolamento do herpesvirus canino 1 na Argentina

Relatam-se o primeiro isolamento de herpesvirus canino 1 (CaHV-1) e a localização atípica das lesões vesiculares associadas a este vírus na Argentina. A amostra foi recuperada de lesões vesiculares, localizadas na parte interna da coxa direita, em uma fêmea de raça Labrador. A cadela tinha quatro anos de idade e era de propriedade privada. O primeiro diagnóstico foi realizado pela reação em cadeia da polimerase e, posteriormente, o vírus foi isolado e sua identificação confirmada por imunofluorescência indireta e pelo teste de neutralização viral.

Desarrollo de un antígeno para diagnóstico del parvovirus de las ratas (virus Kilham) por la técnica de inhibición de la hemaglutinación / [Development of an antigen for the diagnosis of Kilham rat parvovirus by hemagglutination inhibition test]

An antigen of rat parvovirus (Kilham virus) was developed for the diagnosis of viral infection in rat colonies by using hemagglutination inhibition (HAI) test. Primary cell cultures from rat embryos were infected with Kilham rat virus. Infected cells obtained at different time post infection were scraped, centrifuged, concentrated one hundred times, sonicated and centrifuged again. The supernatants obtained were titrated by hemagglutination. The specificity was confirmed with positive and negative reference sera. Ninety eight serum samples were studied by using HAI test. The results coincided with those obtained in a reference laboratory. Kilham rat parvovirus antigen obtained from 5 days-infected-cells was specific, sensitive, easy to prepare, with a high yield and it is useful to detect this virus in experimental and production rat colonies.

Doenca veno-oclusiva do figado:registro de dois casos no nordeste do Brasil. / Veno-occlusive disease of the liver: report of 2 cases in Northeast of Brazil

Sao relatados dois casos tipicos de doenca veno-oclusiva do figado (DVO) em criancas, elevando a cinco o numero de casos no Brasil. Os pacientes foram diagnosticados na fase subaguda (fibrose hepatica central) e na fase cronica (cirrotica), o primeiro atraves de biopsia, complementada pela venografia hepatica e o segundo atraves de necropsia. Sao comentados aspectos do diagnostico diferencial com outras hepatopatias mais frequentes nesta regiao geografica e revistas as possibilidades etiologicas atualmente conhecidas, bem como a distribuicao mundial da DVO do figado

Angiostrongiloidose abdominal. (Apresentacao de um caso). / Abdominal angiostrongyloidiasis. (Report of a case)

Os autores apresentam um caso de angiostrongiloidose abdominal, numa crianca de um ano de idade, do Sudeste do Parana. Baseados nos dados clinicos e anatomo-patologicos identificam o parasito como Angiostrongylus costaricensis